The Gynecologic Oncology division offers a comprehensive program of clinical translational and basic research in gynecologic cancer, education and outstanding patient care. Laboratory research focuses primarily on ovarian cancer while the clinical translational research includes the use of new drugs, innovative new therapies, including vaccines and immunotherapy. Collaborative research is ongoing in stem cell biology, new imaging techniques for screening and monitoring disease, and studies of new biomarkers to determine prognosis. The division has a 3-year post-residency fellowship program in gynecologic oncology.
Our clinical program, located in the Stanford Women's Cancer Center, offers state of the art treatment modalities in a caring, personalized environment. Our patients benefit from the expertise of a highly experienced, interdisciplinary treatment team including Gynecologic Oncologists, Radiation Oncologists, Specialized Oncology Nurses and Social Workers. This team is dedicated to providing the best care while recognizing and helping with the emotional and social aspects of a cancer diagnosis. Stanford offers a multitude of support services for patients and their families. Learn more about our expertise in the treatment of specific gynecologic cancers including:
- Cervical Cancer
- Endometrial/Uterine Cancer
- Ovarian/Fallopian Tube Cancer
- Vaginal Cancer
- Trophoblastic Disease / Molar pregnancies
- Preinvasive Conditions / Dysplasia of Cervix or Vulva / Colposcopy